CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer's Disease

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2018 Mar 9

PMID 29516283

Citations 9

Authors

Ling Li

Fan Zeng

Yu-Hui Liu

Hui-Yun Li

Shu-Yang Dong

Ze-Yan Peng

Yan-Jiang Wang

Hua-Dong Zhou

Affiliations

Soon will be listed here.

Abstract

Polymorphisms of the cholesterol-24S-hydroxylase (CYP46A1) and apolipoprotein E (APOE) genes are risk factors for Alzheimer's disease (AD). Plasma level of 24S-hydroxcholesterol (24-OHC), the metabolite of cholesterol, is thought to correlate with AD. The present study investigated the correlation between these genetic factors and blood 24-OHC and amyloid-beta (Aβ) levels in AD patients. Association analysis, logistic regression, and linear regression were used to analyze the correlation of CYP46A1 and APOE genotypes with blood 24-OHC and Aβ levels and AD risk. We found that the APOEε4 alleles were significantly higher in patients with AD and there was a potential synergistic interaction between the CYP46A1 C allele and APOEε4 allele in AD. Blood 24-OHC level and Aβ level were significantly higher in AD patients than controls, indicating 24-OHC could be a marker in AD diagnosis. However, AD patients with the CYP46A1 TT, but not CC, genotype had higher 24-OHC levels, which indicated that there may be other mechanisms in the relationship between CYP46A1 polymorphisms and AD.

Citing Articles

Plant sterols and cholesterol metabolism are associated with five-year cognitive decline in the elderly population.

Clark C, Gholam M, Zullo L, Kerksiek A, Castelao E, von Gunten A iScience. 2023; 26(6):106740.

PMID: 37250771 PMC: 10209479. DOI: 10.1016/j.isci.2023.106740.

The Antifungal Antibiotic Filipin as a Diagnostic Tool of Cholesterol Alterations in Lysosomal Storage Diseases and Neurodegenerative Disorders.

Bruno F, Camuso S, Capuozzo E, Canterini S Antibiotics (Basel). 2023; 12(1).

PMID: 36671323 PMC: 9855188. DOI: 10.3390/antibiotics12010122.

Connecting the Dots Between Hypercholesterolemia and Alzheimer's Disease: A Potential Mechanism Based on 27-Hydroxycholesterol.

Wu M, Zhai Y, Liang X, Chen W, Lin R, Ma L Front Neurosci. 2022; 16:842814.

PMID: 35464321 PMC: 9021879. DOI: 10.3389/fnins.2022.842814.

Association of cholesterol 7α-hydroxylase (CYP7A1) promoter polymorphism (rs3808607) and cholesterol 24S-hydroxylase (CYP46A1) intron 2 polymorphism (rs754203) with serum lipids, vitamin D levels, and multiple sclerosis risk in the Turkish....

Sezer E, Demirdogen B, Demirkaya S, Bulut G, Akkulak M, Evin E Neurol Sci. 2021; 43(4):2611-2620.

PMID: 34546511 DOI: 10.1007/s10072-021-05597-1.

Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications.

Pikuleva I, Cartier N Front Aging Neurosci. 2021; 13:696778.

PMID: 34305573 PMC: 8297829. DOI: 10.3389/fnagi.2021.696778.

References

Papassotiropoulos A, Lutjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R . 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res. 2002; 36(1):27-32. DOI: 10.1016/s0022-3956(01)00050-4. View

Helisalmi S, Vepsalainen S, Koivisto A, Mannermaa A, Iivonen S, Hiltunen M . Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary. J Neurol Neurosurg Psychiatry. 2006; 77(3):421-2. PMC: 2077714. DOI: 10.1136/jnnp.2005.071928. View

Jick H, Zornberg G, Jick S, Seshadri S, Drachman D . Statins and the risk of dementia. Lancet. 2000; 356(9242):1627-31. DOI: 10.1016/s0140-6736(00)03155-x. View

DErrico G, Vitiello G, Ortona O, Tedeschi A, Ramunno A, DUrsi A . Interaction between Alzheimer's Abeta(25-35) peptide and phospholipid bilayers: the role of cholesterol. Biochim Biophys Acta. 2008; 1778(12):2710-6. DOI: 10.1016/j.bbamem.2008.07.014. View

Garcia A, Muniz M, Silva H, da Silva H, Athayde-Junior L . Cyp46 polymorphisms in Alzheimer's disease: a review. J Mol Neurosci. 2009; 39(3):342-5. DOI: 10.1007/s12031-009-9227-2. View

CHOBANIAN A, Hollander W . Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol. J Clin Invest. 1962; 41:1732-7. PMC: 291095. DOI: 10.1172/JCI104631. View

Li Y, Chu L, Chen Y, Cheung B, Leung R, Yik P . Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients. Dement Geriatr Cogn Disord. 2006; 22(5-6):399-404. DOI: 10.1159/000095723. View

Lund E, Guileyardo J, Russell D . cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci U S A. 1999; 96(13):7238-43. PMC: 22064. DOI: 10.1073/pnas.96.13.7238. View

Kolsch H, Lutjohann D, Jessen F, Popp J, Hentschel F, Kelemen P . CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism. Eur Psychiatry. 2009; 24(3):183-90. DOI: 10.1016/j.eurpsy.2008.12.005. View

10.

Wang F, Jia J . Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese. Brain Res. 2007; 1147:34-8. DOI: 10.1016/j.brainres.2007.02.005. View

11.

Li L, Yin Z, Liu J, Li G, Wang Y, Yan J . CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease. J Neurol. 2012; 260(7):1701-8. DOI: 10.1007/s00415-012-6690-4. View

12.

Lutjohann D, Papassotiropoulos A, Bjorkhem I, Locatelli S, Bagli M, Oehring R . Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res. 2000; 41(2):195-8. View

13.

Vitiello G, Grimaldi M, Ramunno A, Ortona O, De Martino G, DUrsi A . Interaction of a beta-sheet breaker peptide with lipid membranes. J Pept Sci. 2010; 16(2):115-22. DOI: 10.1002/psc.1207. View

14.

Papassotiropoulos A, Streffer J, Tsolaki M, Schmid S, Thal D, Nicosia F . Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol. 2003; 60(1):29-35. DOI: 10.1001/archneur.60.1.29. View

15.

Bjorkhem I, Lutjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J . Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res. 1998; 39(8):1594-600. View

16.

Solomon A, Leoni V, Kivipelto M, Besga A, Oksengard A, Julin P . Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. Neurosci Lett. 2009; 462(1):89-93. DOI: 10.1016/j.neulet.2009.06.073. View

17.

Saher G, Stumpf S . Cholesterol in myelin biogenesis and hypomyelinating disorders. Biochim Biophys Acta. 2015; 1851(8):1083-94. DOI: 10.1016/j.bbalip.2015.02.010. View

18.

LaFerla F, Oddo S . Alzheimer's disease: Abeta, tau and synaptic dysfunction. Trends Mol Med. 2005; 11(4):170-6. DOI: 10.1016/j.molmed.2005.02.009. View

19.

Ma S, Tang N, Lam L, Chiu H . Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population. Int Psychogeriatr. 2006; 18(1):37-45. DOI: 10.1017/S1041610205003108. View

20.

Zatta P, Zambenedetti P, Stella M, Licastro F . Astrocytosis, microgliosis, metallothionein-I-II and amyloid expression in high cholesterol-fed rabbits. J Alzheimers Dis. 2002; 4(1):1-9. DOI: 10.3233/jad-2002-4101. View